PMGC Holdings Inc.
PMGC Holdings Inc. (ELAB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
elab · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for PMGC Holdings Inc. (ELAB) measures how much investors pay for each dollar of the company's trailing earnings. ELAB's current PE ratio of N/A is calculated by dividing its stock price of $1.59 by its TTM earnings per share of -$24.99.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
PMGC Holdings Inc.You ELAB | $3M | N/A | — | -$24.99 |
 Avenue Therapeutics, Inc. ATXI | $1M | N/A | — | -$0.93 |
 BriaCell Therapeutics Corp. Warrant BCTXZ | $0M | N/A | — | -$62.95 |
 Dermata Therapeutics, Inc. DRMA | $1M | N/A | — | -$8.16 |
 Moolec Science S.A. MLEC | $5M | N/A | — | -$258.69 |
 NewcelX Ltd. NCEL | $1M | N/A | — | -$26.31 |
 NKGen Biotech, Inc. Common Stock NKGN | $8M | N/A | — | -$1.54 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-378.74 | — | |
2024-12-31 FY2024 | — | $-6595.29 | — | |
2023-12-31 FY2023 | — | $-47269.42 | — | |
2022-12-31 FY2022 | — | $-15.87 | — | |
2021-12-31 FY2021 | — | $-6.97 | — | |
2020-12-31 FY2020 | — | $-1.98 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for PMGC Holdings Inc. (ELAB) measures how much investors pay for each dollar of the company's trailing earnings. ELAB's current PE ratio of N/A is calculated by dividing its stock price of $1.59 by its TTM earnings per share of -$24.99.
Frequently asked questions
ELAB pe ratio · 6 questionsELAB's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.59 and TTM EPS of -$24.99. Data sourced from Financial Modeling Prep via ELAB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · PMGC Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08